Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PLoS Neglected Tropical Diseases | journal | 2.513 Q1 | 163 | 768 | 1590 | 38387 | 8661 | 1565 | 5.21 | 49.98 |  |
| 2 | Particle and Fibre Toxicology | journal | 2.411 Q1 | 119 | 73 | 147 | 4148 | 1343 | 138 | 7.90 | 56.82 |  |
| 3 | Theranostics | journal | 1.955 Q1 | 158 | 97 | 200 | 6416 | 1627 | 181 | 8.14 | 66.14 |  |
| 4 | International Journal of Neuropsychopharmacology | journal | 1.924 Q1 | 125 | 219 | 445 | 12164 | 2061 | 433 | 4.27 | 55.54 | |
| 5 | Molecular Therapy - Nucleic Acids | journal | 1.727 Q1 | 95 | 78 | 136 | 3913 | 648 | 124 | 4.76 | 50.17 | |
| 6 | Cancer Biology and Therapy | journal | 1.688 Q1 | 130 | 193 | 584 | 7556 | 2160 | 523 | 3.24 | 39.15 | |
| 7 | Protein and Cell | journal | 1.625 Q1 | 94 | 102 | 337 | 5133 | 995 | 314 | 3.02 | 50.32 | |
| 8 | CNS Neuroscience and Therapeutics | journal | 1.619 Q1 | 91 | 149 | 398 | 6211 | 1442 | 306 | 3.37 | 41.68 | |
| 9 | Frontiers in Pharmacology | journal | 1.560 Q1 | 154 | 272 | 444 | 20945 | 1872 | 425 | 4.14 | 77.00 |  |
| 10 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | |
| 11 | Human Genomics | journal | 1.446 Q1 | 68 | 21 | 86 | 778 | 279 | 79 | 2.20 | 37.05 | |
| 12 | International Journal of Pharmaceutics | journal | 1.347 Q1 | 258 | 746 | 2216 | 28029 | 10065 | 2175 | 4.18 | 37.57 |  |
| 13 | International Journal of Nanomedicine | journal | 1.306 Q1 | 179 | 491 | 1274 | 20697 | 6757 | 1259 | 4.97 | 42.15 |  |
| 14 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 |  |
| 15 | Therapeutic Advances in Neurological Disorders | journal | 1.267 Q1 | 68 | 25 | 86 | 1144 | 356 | 83 | 3.88 | 45.76 | |
| 16 | PharmacoEconomics | journal | 1.203 Q1 | 118 | 108 | 270 | 4933 | 708 | 232 | 2.49 | 45.68 | |
| 17 | Emerging Microbes and Infections | journal | 1.165 Q1 | 94 | 48 | 66 | 2923 | 155 | 60 | 2.35 | 60.90 | |
| 18 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.149 Q1 | 64 | 60 | 108 | 3598 | 404 | 105 | 3.74 | 59.97 | |
| 19 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.142 Q1 | 47 | 40 | 55 | 2804 | 208 | 54 | 3.57 | 70.10 | |
| 20 | Cancer Chemotherapy and Pharmacology | journal | 1.141 Q1 | 122 | 285 | 960 | 8854 | 3092 | 938 | 3.35 | 31.07 |  |
| 21 | Nanotechnology, Science and Applications | journal | 1.131 Q1 | 35 | 6 | 18 | 604 | 116 | 18 | 7.63 | 100.67 | |
| 22 | Journal of Nanobiotechnology | journal | 1.109 Q1 | 109 | 59 | 153 | 2388 | 742 | 152 | 4.44 | 40.47 | |
| 23 | PPAR Research | journal | 1.091 Q1 | 59 | 31 | 139 | 1330 | 375 | 133 | 2.76 | 42.90 | |
| 24 | Life Sciences | journal | 1.074 Q1 | 191 | 385 | 933 | 17353 | 2738 | 923 | 2.97 | 45.07 | |
| 25 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | |
| 26 | Cardiovascular Therapeutics | journal | 1.051 Q2 | 54 | 46 | 203 | 1736 | 552 | 194 | 2.75 | 37.74 | |
| 27 | Drug Design, Development and Therapy | journal | 1.034 Q1 | 94 | 235 | 227 | 10969 | 872 | 227 | 3.52 | 46.68 | |
| 28 | Journal of Medical Toxicology | journal | 1.034 Q2 | 58 | 76 | 216 | 1465 | 635 | 177 | 3.44 | 19.28 | |
| 29 | European Journal of Pharmaceutical Sciences | journal | 1.008 Q1 | 163 | 251 | 705 | 12147 | 2709 | 694 | 3.88 | 48.39 | |
| 30 | Altex | journal | 1.006 Q2 | 64 | 52 | 111 | 2399 | 394 | 85 | 3.48 | 46.13 | |
| 31 | Journal of Experimental Pharmacology | journal | 0.994 Q2 | 23 | 1 | 3 | 23 | 9 | 3 | 3.00 | 23.00 | |
| 32 | Toxins | journal | 0.984 Q2 | 116 | 187 | 359 | 10068 | 1201 | 356 | 3.24 | 53.84 | |
| 33 | Core Evidence (discontinued) | journal | 0.983 Q2 | 29 | 13 | 26 | 713 | 105 | 26 | 4.21 | 54.85 | |
| 34 | Journal of Pharmacological Sciences | journal | 0.949 Q2 | 101 | 149 | 437 | 6116 | 1086 | 436 | 2.49 | 41.05 |  |
| 35 | Clinical and Translational Science | journal | 0.941 Q1 | 60 | 77 | 249 | 1782 | 399 | 199 | 1.53 | 23.14 | |
| 36 | Biomarker Insights | journal | 0.937 Q2 | 40 | 13 | 49 | 424 | 133 | 49 | 2.72 | 32.62 | |
| 37 | Human Vaccines and Immunotherapeutics | journal | 0.924 Q2 | 93 | 532 | 721 | 21332 | 1608 | 547 | 2.23 | 40.10 | |
| 38 | Pharmacogenomics and Personalized Medicine | journal | 0.901 Q2 | 37 | 36 | 38 | 2605 | 124 | 38 | 3.41 | 72.36 | |
| 39 | Drug Metabolism and Pharmacokinetics | journal | 0.893 Q1 | 75 | 79 | 237 | 2444 | 620 | 211 | 2.72 | 30.94 | |
| 40 | Journal of Toxicology | journal | 0.890 Q2 | 47 | 33 | 135 | 1508 | 435 | 131 | 2.68 | 45.70 |  |
| 41 | Advances in Pharmacological Sciences | journal | 0.818 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 42 | Pharmacognosy Reviews (discontinued) | journal | 0.817 Q2 | 68 | 19 | 69 | 1377 | 210 | 68 | 1.89 | 72.47 |  |
| 43 | Journal of Pharmaceutical Policy and Practice | journal | 0.814 Q1 | 32 | 61 | 44 | 475 | 66 | 31 | 1.42 | 7.79 | |
| 44 | Biomedicine and Pharmacotherapy | journal | 0.788 Q2 | 149 | 156 | 317 | 5899 | 771 | 312 | 2.37 | 37.81 |  |
| 45 | AAPS PharmSciTech | journal | 0.783 Q1 | 116 | 166 | 462 | 6603 | 1207 | 462 | 2.07 | 39.78 | |
| 46 | Marine Drugs | journal | 0.780 Q2 | 159 | 340 | 674 | 19323 | 2657 | 674 | 3.24 | 56.83 | |
| 47 | Infection and Drug Resistance | journal | 0.777 Q2 | 65 | 35 | 71 | 2165 | 171 | 70 | 2.28 | 61.86 | |
| 48 | Journal of Physiology and Pharmacology | journal | 0.774 Q2 | 89 | 90 | 254 | 5055 | 789 | 254 | 2.64 | 56.17 |  |
| 49 | Chinese Medicine | journal | 0.771 Q2 | 56 | 27 | 93 | 1337 | 262 | 90 | 2.00 | 49.52 | |
| 50 | Pharmaceuticals | journal | 0.765 Q1 | 87 | 56 | 239 | 3813 | 524 | 239 | 2.48 | 68.09 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data